These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19747286)

  • 1. Two novel null alleles of the KEL gene detected in two Chinese women with the K(null) phenotype.
    Yang Y; Wang L; Wang C; Chen H; Guo Z; Zhang Y; Zhu Z
    Transfus Med; 2009 Oct; 19(5):235-44. PubMed ID: 19747286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic basis of the K(0) phenotype in the Swedish population.
    Wester ES; Storry JR; Schneider K; Nilsson Sojka B; Poole J; Olsson ML
    Transfusion; 2005 Apr; 45(4):545-9. PubMed ID: 15819675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Different KEL gene mRNA transcripts in reticulocyte and non-reticulocyte cells].
    Wang L; Yang Y; Wang C; Zhang J; Guo Z; Li Q; Chen H; Zhu Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):520-6. PubMed ID: 18841563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel alleles at the Kell blood group locus that lead to Kell variant phenotype in the Dutch population.
    Ji Y; Veldhuisen B; Ligthart P; Haer-Wigman L; Jongerius J; Boujnan M; Ait Soussan A; Luo G; Fu Y; van der Schoot CE; de Haas M
    Transfusion; 2015 Feb; 55(2):413-21. PubMed ID: 25156717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A McLeod phenotype detected by random screening for K:-4 [Kp(b-)] blood donors in Brazil.
    Wendel S; Fontão-Wendel R; Levi JE; Aravechia MG; Bordokan RF; Russo D; Haddad MS
    Transfusion; 2004 Nov; 44(11):1579-87. PubMed ID: 15504163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic diversity of KELnull and KELel: a nationwide Austrian survey.
    Körmöczi GF; Wagner T; Jungbauer C; Vadon M; Ahrens N; Moll W; Mühlbacher A; Ozgül-Gülce S; Kleinrath T; Kilga-Nogler S; Schönitzer D; Gassner C
    Transfusion; 2007 Apr; 47(4):703-14. PubMed ID: 17381630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A KEL gene encoding serine at position 193 of the Kell glycoprotein results in expression of KEL1 antigen.
    Poole J; Warke N; Hustinx H; Taleghani BM; Martin P; Finning K; Crew VK; Green C; Bromilow I; Daniels G
    Transfusion; 2006 Nov; 46(11):1879-85. PubMed ID: 17076841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two novel Jk(null) alleles derived from 222C>A in Exon 5 and 896G>A in Exon 9 of the JK gene.
    Liu HM; Lin JS; Chen PS; Lyou JY; Chen YJ; Tzeng CH
    Transfusion; 2009 Feb; 49(2):259-64. PubMed ID: 18980618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and functional analyses describe a novel 730delG mutation in the KEL gene causing K0 phenotype in a Taiwanese blood donor.
    Yang MH; Li L; Kuo YF; Hung YS; Yu LC; Hung CS; Tsai SJ; Lin KS; Chu DC
    Transfus Med; 2011 Oct; 21(5):318-24. PubMed ID: 21707797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three novel alleles in the Kell blood group system resulting in the Knull phenotype and the first in a Native American.
    Moulds JM; Persa R; Rierson D; Billingsley KL; Noumsi GT; Hue-Roye K; Reid ME
    Transfusion; 2013 Nov; 53(11 Suppl 2):2867-71. PubMed ID: 23581548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expansion of the Kell blood group system: two new high-prevalence antigens and two novel K0 (Kellnull ) phenotypes.
    Lomas-Francis C; Vege S; Velliquette RW; Fuchisawa A; Uchikawa M; Tani Y; Moro H; Debnath AK; Westhoff CM
    Transfusion; 2013 Nov; 53(11 Suppl 2):2887-91. PubMed ID: 23968329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis of two novel high-prevalence antigens in the Kell blood group system, KALT and KTIM.
    Lee S; Debnath AK; Wu X; Scofield T; George T; Kakaiya R; Yogore MG; Sausais L; Yacob M; Lomas-Francis C; Reid ME
    Transfusion; 2006 Aug; 46(8):1323-7. PubMed ID: 16934067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of the Kell-null phenotype: a mutation at the splice site of human KEL gene abolishes the expression of Kell blood group antigens.
    Yu LC; Twu YC; Chang CY; Lin M
    J Biol Chem; 2001 Mar; 276(13):10247-52. PubMed ID: 11134029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetic analysis for the B subgroup revealing two novel alleles in the ABO gene.
    Cai XH; Jin S; Liu X; Shen W; Lu Q; Wang JL; Fan LF; Sun JL; Liu DZ; Xiang D
    Transfusion; 2008 Nov; 48(11):2442-7. PubMed ID: 18680548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Point mutations characterize KEL10, the KEL3, KEL4, and KEL21 alleles, and the KEL17 and KEL11 alleles.
    Lee S; Wu X; Son S; Naime D; Reid M; Okubo Y; Sistonen P; Redman C
    Transfusion; 1996 Jun; 36(6):490-4. PubMed ID: 8669078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KEL*02 alleles with alterations in and around exon 8 in individuals with apparent KEL:1,-2 phenotypes.
    Wester ES; Steffensen R; Ligthart PC; Vad J; de Haas M; Storry JR; Olsson ML
    Vox Sang; 2010 Aug; 99(2):150-7. PubMed ID: 20384970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhnull syndrome: identification of a novel mutation in RHce.
    Rosa KA; Reid ME; Lomas-Francis C; Powell VI; Costa FF; Stinghen ST; Watanabe AM; Carboni EK; Baldon JP; Jucksch MM; Castilho L
    Transfusion; 2005 Nov; 45(11):1796-8. PubMed ID: 16271106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel silent KEL alleles causing KEL:-5 (Ko) phenotype or discordance between KEL:1,-2 phenotype/KEL*01/02 genotype.
    Martin-Blanc S; Simon P; Gien D; Kappler-Gratias S; Le Pennec PY; Pham BN
    Transfusion; 2013 Nov; 53(11 Suppl 2):2859-66. PubMed ID: 23581578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis for the high-incidence antigens of the Kell blood group system.
    Lee S; Naime DS; Reid ME; Redman CM
    Transfusion; 1997; 37(11-12):1117-22. PubMed ID: 9426633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel KEL*1,3 allele with weak Kell antigen expression confirming the cis-modifier effect of KEL3.
    Körmöczi GF; Scharberg EA; Gassner C
    Transfusion; 2009 Apr; 49(4):733-9. PubMed ID: 19347978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.